arrow
T

Tandile Hermanus

University of the Witwatersrand
H指数:20
被引数:4,029

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

mRNA-1273 SARS-CoV-2 vaccination in people with HIV: an immune correlates analysis of CD4 + T cell responses in the multicenter CoVPN 3008 observational study

mRNA-1273 SARS-CoV-2疫苗接种在HIV感染者中的免疫相关分析:多中心CoVPN 3008观察性研究中CD4+ T细胞反应

2026-09-280
OAAI
Hybrid Immunity in a Mozambican Cohort After 1 or 2 Doses of the BBIBP-CorV Vaccine

莫桑比克队列中接种1剂或2剂BBIBP-CorV疫苗后的混合免疫

2025-06-150
OAAI
A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories

15个实验室SARS-CoV-2抗原性的全球协作比较

2024-12-180
OAAI
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection
2023-11-093
OAAI
Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cells
2023-08-122
OAAI
Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination
2023-08-034
OAAI
Functional HIV-1/HCV cross-reactive antibodies isolated from a chronically co-infected donor
2023-02-017
OAAI
Antibody-dependent cellular cytotoxicity against SARS-CoV-2 Omicron sub-lineages is reduced in convalescent sera regardless of infecting variant
2023-01-018
OAAI
Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition
2022-08-2254
OAAI
Escape from recognition of SARS-CoV-2 variant spike epitopes but overall preservation of T cell immunity
2022-02-0971
OAAI
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial
2021-09-01110
OAAI
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
2021-03-02876
OAAI